Z, W., W, L., F, L., T, Y., W, X., M, L., . . . Y, Z. (2021). Downregulation of lncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press.
Cita Chicago Style (17a ed.)Z, Wang, Liao W, Liu F, Yang T, Xie W, Liao M, Gu D, y Zhang Y. Downregulation of LncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press, 2021.
Cita MLA (8a ed.)Z, Wang, et al. Downregulation of LncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.